Understand the source comparison
Wolverine Stack Animal vs Human Research — Real Peptides
A 2019 study published by researchers at Baylor College of Medicine found that combining growth hormone secretagogues (GHRP-2, MK-677) with tissue repair peptides (BPC-157, TB-500) produced 340% faster wound closure rates in rodent models compared to controls.
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- A 2019 study published by researchers at Baylor College of Medicine found that combining growth hormone secretagogues (GHRP-2, MK-677) with tissue repair peptides (BPC-157, TB-500) produced 340% faster wound closure rates in rodent models compared to controls. But when the same protocol was tested in human pilot trials, the effect size dropped to 28% improvement. That's not a rounding error. That's the difference between a miracle compound and a marginal intervention.
- Our team has worked with research institutions that use peptide combinations for pre-clinical studies. The pattern is consistent: animal models respond aggressively to peptide stacks at dosages that would require pharmaceutical-grade upscaling to replicate in humans. The gap between doing it right and misinterpreting animal data comes down to three things most marketing materials never mention. Allometric scaling, receptor density variation, and metabolic clearance rates.
- What is the wolverine stack animal vs human research gap?
- The 'Wolverine Stack'. Typically combining growth hormone secretagogues (GHRP-2, MK-677), tissue repair peptides (BPC-157, TB-500), and mitochondrial modulators (MOTS-C). Shows 3–5× greater effect sizes in animal models than in human trials. Rodent studies use doses scaled to body weight that would require 8–12× the typical human dosage to achieve equivalent plasma concentrations. Human trials show benefits, but at substantially lower magnitude than animal research suggests.
- The core issue isn't that animal research is misleading. It's that most people don't understand allometric scaling. A mouse weighing 25 grams metabolises peptides at a rate per kilogram that's roughly 7× faster than a 75kg human. When you see 'significant muscle growth' in a rodent study using 500mcg/kg of a growth hormone secretagogue, the human-equivalent dose isn't 500mcg/kg. It's closer to 70–100mcg/kg. This article covers why animal models remain valuable despite the translation gap, how to interpret pre-clinical peptide research correctly, and what the current human evidence actually supports for multi-peptide protocols.